References
- Sundstrom S. Palliative external beam thoracic radiation therapy of non-small cell lung cancer. In: Jeremic B, editor. Advances in radiation oncology in lung cancer. Berlin, Heidelberg: Medical Radiology; 2011; pp 453–9.
- Zwitter M. Dutch statistics on lung cancer: Sobering experience for a new approach. J Thorac Oncol 2012;7: 269–71.
- Alberts WM; American College of Chest Physicians. Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines, 2nd ed. Chest 2007;132:1S–19S.
- Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Winton T, . Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: Long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol 2007;25:313–8.
- Kunitoh H, Kato H, Tsuboi M, Shibata T, Asamura H, Ichinose Y, . Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: Report of Japan Clinical Oncology Group trial 9806. J Clin Oncol 2008;26:644–9.
- Fischer S, Darling G, Pierre AF, Sun A, Leighl N, Waddell TK, . Induction chemoradiation therapy followed by surgical resection for non-small cell lung cancer (NSCLC) invading the thoracic inlet. Eur J Cardiothorac Surg 2008;33:1129–34.
- Phernambucq EC, Spoelstra FO, Paul MA, Senan S, Melissant CF, Postmus PE, . Evaluation of a treatment strategy for optimising preoperative chemoradiotherapy in stage III non-small-cell lung cancer. Eur J Cardiothorac Surg 2009;36:1052–7.
- Fernandes AT, Mitra N, Xanthopoulos E, Evans T, Stevenson J, Langer C, . The impact of extent and location of mediastinal lymph node involvement on survival in stage III non-small cell lung cancer patients treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 2012;83:340–7.
- van Baardwijk A, Wanders S, Boersma L, Borger J, Ollers M, Dingemans AM, . Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer. J Clin Oncol 2010;28:1380–6.